| Ident. | Authors (with country if any) | Title |
|---|
| 000053 (2020) |
Andreas Kerschbaumer [Autriche] ; Josef S. Smolen [Autriche] ; Maxime Dougados [France] ; Maarten De Wit [Suisse] ; Jette Primdahl [Danemark] ; Iain Mcinnes [Royaume-Uni] ; Désirée Van Der Heijde [Pays-Bas] ; Xenofon Baraliakos [Allemagne] ; Louise Falzon [États-Unis] ; Laure Gossec [France] | Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis. |
| 000067 (2020) |
Uddalak Bharadwaj [États-Unis] ; Moses M. Kasembeli [États-Unis] ; Prema Robinson [États-Unis] ; David J. Tweardy | Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution. |
| 000106 (2020) |
Emilie Sbidian [France] ; Anna Chaimani [France] ; Sivem Afach [France] ; Liz Doney [Royaume-Uni] ; Corinna Dressler ; Camille Hua ; Canelle Mazaud ; Céline Phan [France] ; Carolyn Hughes [Royaume-Uni] ; Dru Riddle [États-Unis] ; Luigi Naldi ; Ignacio Garcia-Doval ; Laurence Le Cleach [France] | Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. |
| 000304 (2019) |
Catriona Mccallion [Royaume-Uni] ; Anna D. Peters ; Andrew Booth ; Karen Rees-Unwin [Royaume-Uni] ; Julie Adams [Royaume-Uni] ; Raisa Rahi [Royaume-Uni] ; Alain Pluen [Royaume-Uni] ; Claire V. Hutchinson [Royaume-Uni] ; Simon J. Webb ; John Burthem [Royaume-Uni] | Dual-action CXCR4-targeting liposomes in leukemia: function blocking and drug delivery. |
| 000409 (2019) |
Anshika N. Singh [Inde] ; Neeti Sharma [Inde] | Epigenetic Modulators as Potential Multi-targeted Drugs Against Hedgehog Pathway for Treatment of Cancer. |
| 000432 (2019) |
Anbok Lee [Corée du Sud] ; Sunmi Jo [Corée du Sud] ; Changhu Lee [Corée du Sud] ; Hyun-Hee Shin [Corée du Sud] ; Tae Hyun Kim [Corée du Sud] ; Ki Jung Ahn [Corée du Sud] ; Sung-Kwang Park [Corée du Sud] ; Heunglae Cho [Corée du Sud] ; Hye-Kyoung Yoon [Corée du Sud] ; Woo Gyeong Kim [Corée du Sud] ; Jiyoung Park [Corée du Sud] ; Yunseon Choi [Corée du Sud] | Diabetes as a prognostic factor in HER-2 positive breast cancer patients treated with targeted therapy. |
| 000495 (2019) |
Ammara Akhtar [Pakistan] ; Anam Amir [Pakistan] ; Waqar Hussain [Pakistan] ; Abdul Ghaffar [Pakistan] ; Nouman Rasool [Pakistan] | In Silico Computations of Selective Phytochemicals as Potential Inhibitors Against Major Biological Targets of Diabetes Mellitus. |
| 000520 (2019) |
Jianling Xie [Australie] ; James E. Merrett [Australie] ; Kirk B. Jensen [Australie] ; Christopher G. Proud [Australie] | The MAP kinase-interacting kinases (MNKs) as targets in oncology. |
| 000531 (2018) |
Mikyung Yu [États-Unis] ; Carleena A. Ortega [États-Unis] ; Kevin Si [États-Unis] ; Roberto Molinaro [États-Unis] ; Frederick J. Schoen [États-Unis] ; Renata F C. Leitao [États-Unis, Brésil] ; Xiaoding Xu [États-Unis] ; Morteza Mahmoudi [États-Unis] ; Suyeon Ahn [États-Unis] ; Jerry Liu [États-Unis] ; Phei Er Saw [États-Unis, Corée du Sud] ; In-Hyun Lee [États-Unis, Corée du Sud] ; Mirna M B. Brayner [États-Unis, Brésil] ; Azita Lotfi [États-Unis] ; Jinjun Shi [États-Unis] ; Peter Libby [États-Unis] ; Sangyong Jon [Corée du Sud] ; Omid C. Farokhzad [États-Unis, Arabie saoudite] | Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery. |
| 000546 (2019) |
Coert J. Zuurbier [Pays-Bas] ; Antonio Abbate [États-Unis] ; Hector A. Cabrera-Fuentes [Singapour, Mexique, Russie, Allemagne] ; Michael V. Cohen [États-Unis] ; Massimo Collino [Italie] ; Dominique P V. De Kleijn [Pays-Bas] ; James M. Downey [États-Unis] ; Pasquale Pagliaro [Italie] ; Klaus T. Preissner [Allemagne] ; Masafumi Takahashi [Japon] ; Sean M. Davidson [Royaume-Uni] | Innate immunity as a target for acute cardioprotection. |
| 000617 (2019) |
Wei-Ying Kuo [Taïwan] ; Hung-Ju Hsu [Taïwan] ; Chun-Yi Wu [Taïwan] ; Hong-Sen Chen [Taïwan] ; Yu-Chi Chou [Taïwan] ; Yueh-Liang Tsou [Taïwan] ; Hung-Pin Peng [Taïwan] ; Jhih-Wei Jian [Taïwan] ; Chung-Ming Yu [Taïwan] ; Yi-Kai Chiu [Taïwan] ; Ing-Chien Chen [Taïwan] ; Chao-Ping Tung [Taïwan] ; Michael Hsiao [Taïwan] ; Chia-Lung Lin [Taïwan] ; Yong Alison Wang [Taïwan] ; Andrew H-J Wang [Taïwan] ; An-Suei Yang [Taïwan] | Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft models. |
| 000707 (2018) |
Nadejda Bozadjieva [États-Unis] ; Kristy M. Heppner [États-Unis] ; Randy J. Seeley [États-Unis] | Targeting FXR and FGF19 to Treat Metabolic Diseases-Lessons Learned From Bariatric Surgery. |
| 000817 (2018) |
Christopher P. Denton [Royaume-Uni] ; Voon H. Ong [Royaume-Uni] ; Shiwen Xu [Royaume-Uni] ; Haiyin Chen-Harris [États-Unis] ; Zora Modrusan [États-Unis] ; Robert Lafyatis [États-Unis] ; Dinesh Khanna [États-Unis] ; Angelika Jahreis [États-Unis] ; Jeffrey Siegel [États-Unis] ; Thierry Sornasse [États-Unis] | Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis. |
| 000818 (2018) |
Yen-Wei Huang [Taïwan] ; Chun-Ting Lee [Taïwan] ; Ta-Chen Wang [Taïwan] ; Yun-Chung Kao [Taïwan] ; Chih-Hui Yang [Taïwan] ; Yu-Mei Lin [Taïwan] ; Keng-Shiang Huang [Taïwan] | The Development of Peptide-based Antimicrobial Agents against Dengue Virus. |
| 000941 (2018) |
J W Baddley [États-Unis] ; F. Cantini [Italie] ; D. Goletti [Italie] ; J J G Mez-Reino [Espagne] ; E. Mylonakis [États-Unis] ; R. San-Juan [Espagne] ; M. Fernández-Ruiz [Espagne] ; J. Torre-Cisneros [Espagne] | ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents). |
| 000943 (2018) |
K L Winthrop [États-Unis] ; X. Mariette [France] ; J T Silva [Espagne] ; E. Benamu [États-Unis] ; L H Calabrese [États-Unis] ; A. Dumusc [Suisse] ; J S Smolen [Autriche] ; J M Aguado [Espagne] ; M. Fernández-Ruiz [Espagne] | ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors). |
| 000949 (2018) |
J. Aguilar-Company [Espagne] ; M. Fernández-Ruiz [Espagne] ; R. García-Campelo [Espagne] ; A C Garrido-Castro [États-Unis] ; I. Ruiz-Camps [Espagne] | ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Cell surface receptors and associated signaling pathways). |
| 000979 (2018) |
Navid Aeineh [Iran] ; Fahimeh Salehi [Iran] ; Mohammad Akrami [Iran] ; Firouzeh Nemati [Iran] ; Masoumeh Alipour [Iran] ; Milad Ghorbani [Iran] ; Banafsheh Nikfar [Iran] ; Fatemeh Salehian [Iran] ; Nader Riyahi Alam [Iran] ; Seyed Esmaeil Sadat Ebrahimi [Iran] ; Alireza Foroumadi [Iran] ; Mehdi Khoobi [Iran] ; Mohammadreza Rouini [Iran] ; Maryam Dibaei [Iran] ; Ismaeil Haririan [Iran] ; Mohammad Reza Ganjali [Iran] ; Saeed Safaei [Iran] | Glutathione conjugated polyethylenimine on the surface of Fe3O4 magnetic nanoparticles as a theranostic agent for targeted and controlled curcumin delivery. |
| 000A34 (2018) |
Feng Xie [République populaire de Chine] ; Li Ling [République populaire de Chine] ; Hans Van Dam [Pays-Bas] ; Fangfang Zhou [République populaire de Chine] ; Long Zhang [République populaire de Chine] | TGF-β signaling in cancer metastasis. |
| 000B12 (2017) |
Luca Di Lullo [Italie] ; Claudio Ronco [Italie] ; Antonio Bellasi [Italie] ; Mario Cozzolino [Italie] ; Fulvio Floccari [Italie] ; Vincenzo Barbera [Italie] ; Simone Verdesca [Italie] ; Rodolfo Rivera [Italie] ; Antonio De Pascalis [Italie] ; Anna Mudoni ; Antonio Santoro [Italie] | [Neprilysin inhibition and chronic kidney disease]. |
| 000B37 (2017) |
Xueqian Zhuang [République populaire de Chine] ; Hao Zhang [République populaire de Chine] ; Xiaoyan Li [République populaire de Chine] ; Xiaoxun Li [République populaire de Chine] ; Min Cong [République populaire de Chine] ; Fangli Peng [République populaire de Chine] ; Jingyi Yu [République populaire de Chine] ; Xue Zhang [République populaire de Chine] ; Qifeng Yang [République populaire de Chine] ; Guohong Hu [République populaire de Chine] | Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1. |
